Market Access Mapping the Vertical Integration of Insurers, PBMs, GPOs, Specialty Pharmacies, and Healthcare Services: DCI’s 2026 Update pharminent April 14, 2026
Regulatory MSD, Daiichi Sankyo’s ifinatamab deruxtecan receives FDA priority pharminent April 14, 2026
Other Novo Nordisk and OpenAI forge alliance to drive speedy drug development pharminent April 14, 2026
Regulatory MSD, Daiichi Sankyo’s ifinatamab deruxtecan receives FDA priority pharminent April 14, 2026
Clinical Data Spyre drug for inflammatory bowel disease shows promise in early study pharminent April 13, 2026
Clinical Data Allogene data suggest ‘off-the-shelf’ CAR-T could delay relapse in lymphoma pharminent April 13, 2026
Policy / Pricing FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results pharminent April 13, 2026
Manufacturing USP adds Tamiflu, Trulicity to vulnerable list as upstream analysis reshapes supply concerns pharminent April 13, 2026
Clinical Data Allogene stock sails after CAR T clears residual lymphoma in early data cut pharminent April 13, 2026
Other 220: An Interview With Dr. Jaime Moore on Obesity Medications and Neuromuscular Disease pharminent April 13, 2026
Clinical Data Revolution rises 40% as pancreatic cancer drug doubles survival pharminent April 13, 2026
Regulatory IDEAYA and Servier’s eye cancer drug heads to FDA after delivering ‘best in class’ efficacy pharminent April 13, 2026
M&A / Deals AbbVie enters world of pain in up to $715M deal with China’s Haisco pharminent April 13, 2026
Regulatory FDA issues complete response letter to Replimune’s RP1 for melanoma pharminent April 13, 2026
Regulatory FDA issues complete response letter to Replimune’s RP1 for melanoma pharminent April 13, 2026
M&A / Deals Oricell closes a ‘pre-IPO’ megaround to aim CAR-T at solid tumors pharminent April 10, 2026
Policy / Pricing RFK Jr. rewrites ACIP rules; Gilead, Roche dig into protein degraders pharminent April 10, 2026
Commercial With oral obesity race underway, all eyes are on Lilly’s Foundayo launch pharminent April 10, 2026
Regulatory GSK again pulls application for leucovorin, touted by FDA as potential autism treatment pharminent April 10, 2026
M&A / Deals Roche and C4 Therapeutics to advance degrader-antibody conjugates research pharminent April 10, 2026
M&A / Deals Gan & Lee and JW Pharmaceutical agree on bofanglutide commercialisation pharminent April 10, 2026
Other Precision Medicine in Early Oncology Trials: Biomarkers as Strategic Drivers pharminent April 10, 2026
Regulatory Teva Receives FDA Approval of Denosumab Biosimilar and Filing Acceptances by FDA and EMA For Omalizumab Biosimilar pharminent April 9, 2026
Commercial Lilly launches GLP-1 pill, kicking off showdown with Novo Nordisk pharminent April 9, 2026
Other Avalyn plots IPO to push inhaled pulmonary fibrosis pipeline through clinic pharminent April 9, 2026
M&A / Deals Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb pharminent April 9, 2026
